Introduction {#sec1}
============

Despite the development of echocardiographic quantitative methods for myocardial function assessment, the subjective, visual analysis of thickening remains the standard for the evaluation of left ventricular (LV) contractility during stress testing \[[@cit0001]--[@cit0010]\]. Previous studies revealed inhomogeneity of regional myocardial velocities defined as criteria for impaired function during stress. Katz *et al.* proposed velocities in basal and middle LV segments below 5.5 cm/s as the criterion of ischemia during dobutamine stress echocardiography (DSE) \[[@cit0011]\]. Cain *et al.* defined a cut-off \< 7 cm/s in basal septal and inferior walls, \< 5 cm/s in mid segments of these walls, \< 6 cm/s for basal segments of anterior, lateral and posterior walls, and \< 4 cm/s in mid anterior, lateral and posterior segments \[[@cit0012]\]. However, tissue Doppler parameters provided lower than expected sensitivity when tested in the MYDISE study \[[@cit0013]\]. The introduction of deformation parameters offered the advantage of independence from tethering by adjacent segments. When calculated as a conversion of tissue Doppler velocities, they are still dependent on the angle of insonation and less useful for the apical region \[[@cit0014]--[@cit0019]\]. Recently, a method based on two-dimensional speckle tracking echocardiography (STE) has been introduced with modifications, including automated function imaging (AFI), delivering results in the ser-friendly form of polar maps \[[@cit0020]--[@cit0023]\]. Nevertheless, whereas the assessment of global LV function has started to be incorporated into clinical practice, there is still a paucity of data concerning more time-consuming and hard to interpret regional deformation. Especially the data concerning dynamic changes of segmental strain during stress echocardiography are very limited \[[@cit0024]\]. The changes of regional deformation between baseline and peak stages of a stress test have not been described, and the potential differences for various stressors (exercise, dobutamine, rapid pacing, dipyridamole) are awaiting examination. Published data suggest some segmental heterogeneity of deformation parameters, which may impede the identification of universal cut-off values for the detection of ischemia.

That was why the aim of our study was to analyze regional values and the changes of systolic longitudinal strain (SLS) of each particular segment of the LV at rest and at the peak stage of DSE and to test the hypothesis of their homogeneity in the setting of a stress test.

Material and methods {#sec2}
====================

Study group and protocol {#sec2.1}
------------------------

We performed DSE with early atropine administration in 250 consecutive subjects with symptoms of angina. The protocol included: physical examination, electrocardiography and basic laboratory data, transthoracic echocardiography and DSE. All patients were in a sinus rhythm and free of significant valve disease. Further analysis included 238 patients with diagnostic stress echocardiography -- when the test was terminated because of ischemia or reaching the age-predicted heart rate limit (85% × (220 -- age)). All these patients had an angiographic examination of coronary arteries no later than three months after DSE. A diameter stenosis of ≥ 50% in the left main coronary artery or ≥ 70% in other epicardial arteries was defined as significant. After a coronary imaging study, we selected 111 patients (68 female, mean age: 60 ±10 years) without significant lesions in coronary arteries to analyze the regional longitudinal strain at rest and the peak stage of the stress test, as well as the changes of deformation parameters between baseline and the peak level of DSE. The study was limited to 111 subjects without significant coronary artery stenoses to avoid the influence of ischemia on regional LV function. We calculated the indices of dispersion for comparison of segmental deformation heterogeneity at rest and stress and for basal, mid and apical regions of the LV. The demographic characteristics of the group without coronary stenoses are presented in [Table I](#t0001){ref-type="table"} and the echocardiographic parameters in [Table II](#t0002){ref-type="table"}. All subjects gave written informed consent to participate in the study, and the protocol was approved by the Ethical Commission of the Medical University of Lodz (number of agreement RNN/119/10 KE from 13.07.2010).

###### 

Demographic characteristics, clinical data and treatment of the studied subjects without significant coronary stenoses

  Parameter in studied group (*n* = 111)   Mean ± SD            Range
  ---------------------------------------- -------------------- ----------------
  Age \[years\]                            60 ±10               38--79
  Height \[cm\]                            167 ±8               150--187
  Body mass \[kg\]                         79 ±15               45--115
  Body mass index \[kg/m^2^\]              29 ±5                18--44
  Body surface area \[m^2^\]               1.92 ±0.21           1.41--2.43
  Blood pressure systolic \[mm Hg\]        127 ±17              90--170
  Blood pressure diastolic \[mm Hg\]       71 ±10               43--100
  Heart rate \[min^--1^\]                  66 ±10               40--86
  Total cholesterol \[mg/dl\]              207 ±42              96--331
  Cholesterol LDL \[mg/dl\]                122 ±33              40--212
  Cholesterol HDL \[mg/dl\]                56 ±12               31--95
  **Parameter**                            ***N* or *n* (%)**   **Percentage**
  Female/male                              68/43                61/39
  Chest pain:                                                   
   Typical                                 36                   32
   Atypical                                58                   52
   Non-specific                            17                   15
  Hypertension                             87                   78
  Diabetes                                 25                   23
  Smoking                                  53                   48
  Hypercholesterolemia                     88                   79
  Family history of coronary disease       20                   18
  Acetylsalicylic acid                     83                   75
  Clopidogrel                              10                   9
  β-Adrenolytic                            63                   57
  ACE inhibitor                            68                   61
  Statin                                   80                   72
  Long-acting nitrates                     22                   20

ACE -- angiotensin-converting enzyme.

###### 

Echocardiographic parameters of the studied subjects without significant coronary stenoses

  Parameter in studied group (*n* = 111)   Mean ± SD     Range
  ---------------------------------------- ------------- ----------
  LVd \[mm\]                               46.5 ±4.5     35--58
  LVs \[mm\]                               31.7 ±4.7     22--47
  PWd \[mm\]                               10.9 ±1.5     8--15
  PWs \[mm\]                               14.0 ±1.6     10--19
  IVSd \[mm\]                              11.3 ±1.7     8--15
  IVSs \[mm\]                              14.3 ±1.6     11--19
  Ao \[mm\]                                32.1 ±3.8     25--45
  LA \[mm\]                                39.4 ±3.9     30--51
  RV \[mm\]                                26.0 ±2.2     20--30
  E/A                                      0.94 ±0.3     0.4--1.9
  LV mass \[g\]                            223 ±62       102--392
  LV mass index \[g/m^2^\]                 116.2 ±27.9   59--195
  ESV at baseline \[ml\]                   22.1 ±9.2     8--62
  EDV at baseline \[ml\]                   54.3 ±15.8    28--105
  SV at baseline \[ml\]                    32.4 ±9.6     14--61
  EF at baseline (%)                       60 ±9.0       37--76
  WMSI at baseline                         1.04 ±0.09    1.0--1.5
  S' lat at baseline \[cm/s\]              8.7 ±2.2      5--14
  E' lat at baseline \[cm/s\]              10.6 ±2.7     4--18
  ESV at peak \[ml\]                       12.9 ±5.5     4--31
  EDV at peak \[ml\]                       39.5 ±12.6    11--74
  SV at peak \[ml\]                        26.8 ±9.2     6--47
  EF at peak (%)                           67.8 ±8.2     44--85
  WMSI at peak                             1.08 ±0.11    1.0--1.5
  S' lat at peak \[cm/s\]                  14.9 ±4.1     5--23
  E' lat at peak \[cm/s\]                  15.5 ±3.6     7--22

N -- number of subjects, LVd -- left ventricular end diastolic dimension, LVs -- left ventricular end systolic dimension, PWd -- end diastolic left ventricular posterior wall thickness, PWs -- end systolic left ventricular posterior wall thickness, IVSd -- end diastolic left ventricular septum thickness, IVSs -- end systolic left ventricular septum thickness, Ao -- aortic dimension, LA -- left atrial dimension, RV -- right ventricular end diastolic dimension, E/A -- ratio of early to atrial mitral inflow peak velocity, LV mass -- left ventricular mass, LV mass index -- left ventricular mass index, ESV -- end systolic left ventricular volume, EDV -- end diastolic left ventricular volume, SV -- stroke volume, EF -- left ventricular ejection fraction, WMSI -- wall motion score index, S' lat -- peak systolic velocity of lateral part of mitral annulus, E' lat -- peak early diastolic velocity of lateral part of mitral annulus.

Echocardiographic assessment {#sec2.2}
----------------------------

We used an 18-segment model of LV, dividing each wall into three segments: basal, mid and apical. The evaluation of systolic function was performed by consensual visual assessment of two expert readers.

Dobutamine stress echocardiography {#sec2.3}
----------------------------------

Dobutamine was administered by intravenous infusion in doses of 10, 20, 30 and 40 µg/kg/min during 3-minute stages, and atropine was added in 0.5 mg boluses after the second stage up to the dose of 2 mg. Blood pressure was measured during each stage, and 12-lead ECG was recorded immediately after termination of the test.

The infusion was stopped when induced wall motion abnormalities suggestive for ischemia, chest pain, arrhythmia, excessive blood pressure increase or hypotension occurred or the age-predicted heart rate was reached. Video loops of heart cycles were acquired using standard echocardiographic views (three apical and LV short-axis view at three levels) and digitally stored for further analysis.

Assessment of myocardial deformation {#sec2.4}
------------------------------------

Calculation of deformation parameters was performed off-line on an EchoPac 6.1.0 workstation (GE Vingmed Ultrasound). SLS values were obtained by 2D STE requiring manual tracing of endocardium in three apical views. In order to make the process of obtaining regional data more efficient, we assigned LV segments in clockwise order starting with the basal septum in the 4-chamber view, through the 2-chamber to 3-chamber view with consecutive numbers -- see polar maps in [Figures 1](#f0001){ref-type="fig"}--[3](#f0003){ref-type="fig"}. For each LV segment the peak SLS values were measured at baseline and the peak level of DSE (SLS~B~, SLS~P~ respectively) as maximal values recorded before aortic valve closure.

![Mean values of regional systolic longitudinal strain and strain rate at baseline\
STE -- speckle tracking echocardiography, AFI -- automated function imaging, 0 -- baseline stage of dobutamine test, 4ch -- four chamber segments visualized in four-chamber view, 2ch -- two chamber segments visualized in two-chamber view, 3ch -- three chamber segments visualized in three-chamber view. Numbers on bar graphs correspond to polar map location of individual segments.](AMS-13-27762-g001){#f0001}

![Mean values of regional systolic longitudinal strain and strain rate at peak stage of dobutamine stress echocardiography\
STE -- speckle tracking echocardiography, AFI -- automated function imaging, 1 -- peak stage of dobutamine test, 4ch -- four chamber segments visualized in four-chamber view, 2ch -- two chamber segments visualized in two-chamber view, 3ch -- three chamber segments visualized in three-chamber view. Numbers on bar graphs correspond to polar map location of individual segments.](AMS-13-27762-g002){#f0002}

![Segments with highest and lowest strain at baseline and peak stage of DSE. **A** -- Polar plots showing segments with the highest (\> 20%) and lowest (\< 15%) absolute values of systolic longitudinal strain in patients without significant coronary stenoses. Dark speckles indicate segments with SLS \> 20%, white speckles indicate segments with SLS \< 15%. **B** -- Polar plots showing segments with the highest (\> 18%) and the lowest (\< 14%) absolute values of systolic longitudinal strain in patients with significant coronary stenoses. Dark speckles indicate segments with SLS \> 18%, white speckles indicate segments with SLS \< 14%](AMS-13-27762-g003){#f0003}

The alternative method for obtaining SLS, i.e. AFI, required indicating three points (two basal and one apical) in each apical view and accepting the proposed region of interest encompassing the myocardial width. The regional values of peak SLS were presented in the format of a polar LV map with information describing averaged (from 6 segments) and global (from 18 segments) parameters.

Statistical analysis {#sec2.5}
--------------------

Statistical analysis was performed using MedCalc V. 12.1.4. (Frank Schoonjans Belgium). Continuous variables were expressed as means and standard deviations. Mean values of deformation parameters in 18 segments were compared with ANOVA or, when the equality of variances was not confirmed in Levene's test, with the Kruskal-Wallis test. *P* \< 0.05 was considered significant. The dispersion index for strain at baseline and at the peak stage of DSE was defined as the average of the segmental standard deviations of strain values in the segments composing specific regions. We calculated the dispersion index (DI) for all 18 LV segments and separately for basal, mid and apical regions. Comparison of DI at baseline and the peak stage of DSE was performed with the paired *t*-test. The coefficient of variation for duplicate measurements of regional SLS and AFI was calculated to assess intraobserver and interobserver variability for regional deformation in 15 randomly selected patients.

Results {#sec3}
=======

The mean resting heart rate was 66 ±10 beats per minute and increased during DSE to 143 ±12, *p* \< 0.001. Similarly, a significant increase was observed for the systolic and diastolic blood pressure: from 127 ±17 mm Hg at baseline to 143 ±27 mm Hg at stress (*p* \< 0.001), and from 71 ±10 mm Hg to 77 ±13 mm Hg (*p* \< 0.001), respectively. The average achieved dose of dobutamine infusion was 35 µg/kg/min and atropine dose 0.9 ±0.5 mg. The feasibility of deformation parameters was ≥ 95%. Detailed data concerning the feasibility in consecutive LV segments were published previously \[[@cit0025]\].

Intraobserver and interobserver variability assessed for segmental values of strain in the basal segment of the posterior septum was 8.0% and 8.3% for SLS at baseline and 13.2% and 12.4% at peak. For AFI the respective coefficients of variance were 8.2% and 8.7% for baseline and 15.7% and 16.3% for peak stage measurements.

Significant heterogeneity of SLS values among the LV segments (measured both by AFI and STE, *p* \< 0.001) was observed at baseline and the peak stage of DSE. The lowest absolute values of SLS at baseline were observed in the anterior wall (segments 10, 11, 12, with SLS~B~ 14.2 ±6.2%, 13.1 ±6.2% and 14.1 ±6.9% respectively) and the highest in the basal and mid segment of the inferior wall (segments 7 and 8, with SLS~B~ 20.5 ±5.2% and 20.8 ±4.6%) and in the apical segment of the posterior septum (segment 3 with SLS~B~ 20.1 ±4.6%); see [Figure 1](#f0001){ref-type="fig"}. Similarly, resting strain values obtained by the AFI method were the lowest in the mid and basal anterior wall (AFI~B~ 15.2 ±6.6% and 14.8 ±7.5% in segments 11 and 12 respectively) and the highest in the apical segment of the posterior septum (segment 3, with AFI~B~ 22.2 ±4.9%) and in the mid and apical segments of the inferior wall (segments 8 and 9, with AFI~B~ 21.2 ±4.6% and 21.3 ±5.3%); see [Table III](#t0003){ref-type="table"}.

###### 

Comparison of the regional strain (classical and AFI) at baseline and at the peak stage of dobutamine stress echocardiography (DSE). The numbers in the headings of columns signify successive segments of the left ventricle as shown on polar maps in figures. Marked columns represent apical segments of the left ventricle

  Parameter    1           2             3             4             5             6             7
  ------------ ----------- ------------- ------------- ------------- ------------- ------------- -------------
  SLS~B~ (%)   --18 ±4     --19.9 ±3.7   --20.1 ±4.6   --15.8 ±6     --15.6 ±5.3   --17.2 ±6     --20.5 ±5.2
  SLS~P~ (%)   --18 ±6.2   --19.6 ±5.2   --20.9 ±6.4   --16.6 ±7.8   --12.4 ±7.4   --13.1 ±7.2   --18.2 ±5.9
  ΔSLS (%)     0.04 ±6.0   0.33 ±5.2     --0.82 ±6.5   --0.73 ±7.4   3.6 ±7.6      4.5 ±8.5      2.5 ±6.7
  AFI~B~ (%)   --18 ±4.4   --20 ±3.9     --22.2 ±4.9   --19.1 ±6.5   --16.1 ±5.9   --15.8 ±5.7   --20.4 ±5.2
  AFI~P~ (%)   --18 ±6.4   --20 ±5.5     --23 ±7.1     --19.5 ±8.8   --13.9 ±7     --12.1 ±7.5   --18 ±6.9
  ΔAFI (%)     0.17 ±6.4   0.05 ±5.5     --0.79 ±7.1   --0.38 ±8     2.34 ±7.1     3.93 ±8.65    2.7 ±7.9

  Parameter    8             9             10            11            12            13
  ------------ ------------- ------------- ------------- ------------- ------------- -------------
  SLS~B~ (%)   --20.8 ±4.6   --19.2 ±4.6   --14.2 ±6.2   --13.1 ±6.2   --14.1 ±6.9   --18.2 ±6
  SLS~P~ (%)   --18.9 ±5.8   --20.3 ±6.9   --17.3 ±7.9   --13.1 ±6.1   --12.1 ±5.9   --14.8 ±7.2
  ΔSLS (%)     1.9 ±6.1      --1.3 ±7.3    --3.2 ±7.7    0.2 ±6.8      2.2 ±7.5      3.5 ±8.3
  AFI~B~ (%)   --21.1 ±4.6   --21.3 ±5.3   --17.5 ±7     --15.2 ±6.6   --14.8 ±7.5   --17.5 ±5.8
  AFI~P~ (%)   --18.7 ±6.5   --21.2 ±6.8   --19.9 ±8     --15.8 ±7.4   --13.6 ±7.6   --12.9 ±9.6
  ΔAFI (%)     2.4 ±6.9      --0.06 ±6.8   --2.4 ±7.3    --0.33 ±7.1   1.8 ±8.6      5.0 ±9.6

  Parameter    14            15            16            17            18            *P*-value
  ------------ ------------- ------------- ------------- ------------- ------------- -----------
  SLS~B~ (%)   --17.5 ±5.1   --16.2 ±6.2   --17 ±6.4     --17.8 ±4.2   --16.7 ±4.0   \< 0.001
  SLS~P~ (%)   --14.3 ±6.1   --16.9 ±7.8   --19.2 ±7.1   --17 ±5.4     --14.6 ±5.3   \< 0.001
  ΔSLS (%)     3.3 ±6.4      --0.72 ±8.5   --2.0 ±9.3    0.75 ±6.8     2.2 ±6.7      \< 0.001
  AFI~B~ (%)   --17.5 ±5.3   --18 ±6.7     --19.5 ±6.8   --19.4 ±5.1   --18.3 ±4.5   \< 0.001
  AFI~P~ (%)   --14.3 ±7.7   --20.3 ±8.7   --23.2 ±8.7   --19.9 ±7     --16.5 ±6.7   \< 0.001
  ΔAFI (%)     3.3 ±7.5      --2.1 ±9.2    --3.9 ±9.3    --0.5 ±7.5    1.7 ±7.5      \< 0.001

SLS -- systolic longitudinal strain, B -- baseline stage of DSE, P -- peak stage of DSE, Δ -- change between baseline and peak stage.

During the peak stage of DSE, SLS~P~ was the lowest in the basal anterior (12.1 ±5.9%) and mid lateral segments (12.4 ±7.4%) and the highest in apical segments of the posterior septum (20.9 ±6.4%) and inferior wall (20.3 ±6.9%). In AFI analysis during the peak stage of DSE the lowest value was observed in basal segments of the lateral and posterior wall (12.1 ±7.5% and 12.9 ±9.6% respectively) and the highest values in apical segments of the posterior and anterior septum (23 ±7.1% and 23.2 ±8.7%); see [Figure 2](#f0002){ref-type="fig"}.

Since the results concerning regional analysis of all 18 segments are difficult to follow, we presented in schematic polar maps segments with the maximal (\> 20%) and minimal absolute values (\< 15%) of SLS and AFI during baseline and peak stages of DSE; see [Figure 3](#f0003){ref-type="fig"}. Additionally we analyzed the segmental SLS in 127 patients with significant stenoses of coronary arteries. The variability of strain values was still observed, with a similar pattern of segments with the highest and the lowest deformation as observed in the group without stenoses. Nevertheless, in patients with coronary artery disease (CAD) the absolute values of segmental strain were lower than in subjects without coronary lesions. We have presented a summary of our analysis of patients with CAD in panel B of [Figure 3](#f0003){ref-type="fig"}.

During DSE we observed an increase of the absolute value of SLS in apical LV segments (gray cells in [Table III](#t0003){ref-type="table"}) and a decrease in basal and middle segments. These opposite directions of SLS changes were in the majority of segments confirmed in AFI analysis ([Figure 4](#f0004){ref-type="fig"}). Although systolic longitudinal strain rate (SLSR) values increased in all LV segments approximately twofold during dobutamine infusion, statistically significant differences between the segments emerged. The highest increase of SLSR was recorded in apical septal segments (posterior septum, 1.56 ±0.9 s^--1^ and anterior septum, 1.51 ±1.09 s^--1^) and the smallest increase in the middle segments of the lateral and posterior wall (0.95 ±0.83 s^--1^, and 1.05 ±0.73 s^--1^).

![Mean values of changes in regional systolic longitudinal strain and strain rate between peak and baseline stage of dobutamine stress echocardiography\
STE -- speckle tracking echocardiography, AFI -- automated function imaging, S -- strain, SR -- strain rate, Δ -- change between peak and baseline stage of dobutamine test for respective parameter, 4ch -- four chamber segments visualized in four-chamber view, 2ch -- two chamber segments visualized in two-chamber view, 3ch -- three chamber segments visualized in three-chamber view. Numbers on bar graphs correspond to polar map location of individual segments.](AMS-13-27762-g004){#f0004}

Dispersion indices (DI) of all deformation parameters (SLS, AFI and SLSR) calculated for the whole left ventricular muscle (18 segments) increased significantly during DSE (*p* \< 0.0001 for all). Baseline DI values for SLS, AFI and SLSR were respectively: 5.29 ±0.98, 5.65 ±1.02 and 0.33 ±0.07. At the peak stage of DSE DI for SLS, AFI and SLSR increased respectively to: 6.53 ±0.89, 7.44 ±1.02 and 0.87 ±0.14. A comparison of dispersion indices of SLS, AFI and SLSR between baseline and the peak stage of DSE is presented in [Figure 5](#f0005){ref-type="fig"}. The calculation of a separate dispersion index for basal, middle and apical segments of the LV revealed the highest values of DI in apical LV segments and the lowest in mid segments, although these differences achieved significance only at the peak stage of DSE ([Table IV](#t0004){ref-type="table"}).

###### 

Comparison of dispersion indexes between basal, middle and apical segments of the left ventricle

  Parameter   Basal segments   Mid segments   Apical segments   *P*-value
  ----------- ---------------- -------------- ----------------- -----------
  SLS~B~      5.35 ±1.18       4.85 ±0.88     5.67 ±0.84        NS
  SLS~P~      6.28 ±0.77       6.00 ±0.78     7.32 ±0.61        0.016
  AFI~B~      5.52 ±1.13       5.23 ±0.95     6.20 ±0.88        NS
  AFI~P~      7.78 ±1.18       6.85 ±0.78     8.02 ±0.88        NS
  SLSR~B~     0.35 ±0.08       0.28 ±0.04     0.37 ±0.05        NS
  SLSR~P~     0.93 ±0.15       0.73 ±0.05     0.95 ±0.08        0.004

SLS -- systolic longitudinal strain, AFI -- systolic longitudinal strain measured by automated function imaging, SLSR -- systolic longitudinal strain rate, B -- baseline stage of DSE, P -- peak stage of DSE.

![Comparison of dispersion indices (DI) of deformation parameters between baseline and peak stage of DSE. Black bars indicate DI of SLS, gray bars indicate DI of AFI, and white bars indicate DI of SLSR\
p \< 0.0001 for all comparisons between baseline and peak](AMS-13-27762-g005){#f0005}

Our results indicate significant variability of regional deformation parameters of LV at rest and at the peak stage of DSE in the subjects without significant coronary artery stenoses. The resting SLS presented the lowest values in the anterior and lateral wall, supplied usually by the left coronary artery, and the highest values in the inferior wall and posterior septum, which belong to the territory of the right coronary artery. At the peak stage of dobutamine infusion, the highest amplitudes of strain were registered in the apical segments, although the pattern of higher strain in the right coronary artery region was generally preserved; for an example of DSE in a woman with normal coronary arteries ([Figure 6](#f0006){ref-type="fig"}).

![Strain patterns during baseline and peak stage of DSE in a woman without coronary artery disease. Panel **A** presents polar plot obtained at baseline at heart rate 83 beats/minute. Range of absolute values of segmental strain is from 17% to 24%, mean absolute value of segmental strain in apical region is 20%, in mid-segments 21%, and in basal segments 21%. Panel **B** presents polar plot obtained at peak DSE at heart rate 171 beats/minute. Range of absolute values of segmental strain is from 11% to 46%, mean absolute value of segmental strain in apical region is 35%, in mid-segments 22%, and in basal segments 17%. A distinct increase was observed according to the absolute value of regional strain in the apical region, whereas in the basal region a mild decrease was observed](AMS-13-27762-g006){#f0006}

In our study we did not observe fatal or life-threatening complications related directly to DSE in the whole studied group of 250 patients. The analysis of DSE in 111 patients without significant coronary stenoses revealed 14 adverse events including: 2 cases of prolonged stenocardial pain, 2 hypertensive reactions, numerous ventricular extrasystoles in 5 patients, and single events of hypotonia, bradycardia, induction of left bundle branch block, spontaneously remitting supraventricular tachycardia and atrial fibrillation managed by electrical cardioversion on the next day. The percentage of these mild complications was 12.6%, which is close to the value of 10% of complications during stress tests reported in the literature.

Discussion {#sec4}
==========

According to our knowledge, only a handful of studies evaluating the variability of regional deformation parameters have been published to date, and papers concerning heterogeneity during DSE or other stress tests are still unique.

Afonso *et al.* \[[@cit0026]\] postulated that the strain dispersion index reflecting non-uniformity of myocardial function may be helpful in differentiation between hypertrophic cardiomyopathy and hypertrophy in athletes and hypertensives. Subjects with hypertrophic cardiomyopathy presented not only lower absolute values of global longitudinal strain but also higher dispersion of regional strain (DI = 4.6 ±1.7) in comparison with hypertensive (DI = 3.5 ±1) and athletic hypertrophy (DI = 2.6 ±0.5). Hypertensive hypertrophy was characterized by similar global strain values to those in athletes (which in turn were close to values observed in healthy subjects) but differed in the significantly higher dispersion index of strain. Calculated in an analogous way, in our study the dispersion index of strain measured by the AFI method was 5.65 ±1.02 at rest, which was more similar to values observed in subjects with myocardial hypertrophy than the significantly younger and very small control group in Afonso's study (the mean age of 12 subjects of the control group was 29.3 ±6.3 years). However, mean values of systolic and early diastolic mitral annulus motion measured at rest in our group corresponded to well-preserved systolic and diastolic function (see [Table II](#t0002){ref-type="table"}).

Regarding the profile of regional strain in healthy subjects, Sun *et al.* \[[@cit0027]\] observed higher value of longitudinal and circumferential strain in apical versus basal segments. In the study of Marwick *et al.* \[[@cit0028]\], higher values of longitudinal strain at rest were observed in the majority of apical segments and, similarly to our results, in the inferior wall. Also the more recent paper dedicated to determination of reference values of strain by three-dimensional speckle tracking echocardiography revealed significant heterogeneity in longitudinal strain between individual segments \[[@cit0029]\]. It seems possible that the observed variability of deformation reflects not only the complex geometry and three-layer architecture of the LV but also some differences of perfusion in the field of both coronaries. In the left anterior descending artery the dominance of the diastolic phase of the flow spectrum is more evident than in the right coronary artery, which may have some impact on contractile function, especially during tachycardia at the peak stage of DSE.

Interestingly, also SLS changes observed during DSE displayed significant region-related dispersion, with an increase in the apical and decrease in the basal and middle LV segments. This opposite direction of changes in regional deformation at different LV levels indicates the need for differentiation of segment- or region-specific cut-off values for deformation-based ischemia detection during DSE.

We observed a significant increase of dispersion for strain and strain rate at the peak stage of DSE, and at this stage of the stress test segmental non-uniformity was more pronounced in the apical and less so in mid LV segments ([Figure 5](#f0005){ref-type="fig"} and [Table IV](#t0004){ref-type="table"}). A potential solution of this problem is the choice of marker segments, representative for the territory of each coronary artery, from mid LV segments presenting with lower dispersion indices.

Poorly examined issues also include the changes and dispersion of regional strain during other stress tests such as exercise on a treadmill, pacing or dipyridamole studies. Nowadays, the changes of deformation during exercise are intensively studied and sometimes reveal data which (analyzed in abstraction from achieved heart rate) seem to be contradictory, indicating e.g. physiologic lack of increase of longitudinal strain during maximal exercise (swimming) in healthy athletes \[[@cit0030]\] and poor prognosis related to lowered global longitudinal strain during moderate exercise (bicycle, level of HR 90--100 beats per minute for speckle tracking analysis) in patients with heart failure and preserved ejection fraction \[[@cit0031]\]. Despite the lack of data concerning variability of segmental deformation, it seems probable that the main determinant of strain values lies primarily in heart rate and inotropic excitement achieved rather than in specificity of the applied stressor.

Our study has several limitations. Our group was limited in size and the subjects did not undergo a study of deformation with an alternative method, e.g. myocardial tagging in magnetic resonance imaging. We studied patients without significant lesions of coronary arteries but with a high percentage of cardiovascular risk factors and chest pain. Therefore our results do not necessarily reflect the findings in normal subjects but still may serve as a reference for typical patients referred for a stress test. The assessment of coronary arteries was based on diameter assessed by an experienced invasive cardiologist but was not supported by advanced approaches, e.g. fractional flow reserve or intracoronary ultrasound.

The significant burden of CAD risk factors, such as hypertension and diabetes, and cardiovascular medications may have influenced myocardial function although probably in a homogeneous manner without a predilection to specific regions \[[@cit0032]\]. We focused on the comparisons of dispersion indices between baseline and the peak stage of DSE and in separate regions of the LV, did not assess the impact of age, sex or regional thickness of the myocardium on variability of strain, and did not analyze the potential relationship of strain heterogeneity with different types of coronary circulation: right or left coronary artery dominance. Finally, our analysis was limited to the amplitudes of deformation parameters, whereas variability of time intervals may also provide significant information \[[@cit0033]\].

In conclusion, our data indicate heterogeneity of segmental deformation in patients without significant lesions in coronary arteries undergoing stress testing. This variability is related to basal, middle or apical localization of LV segments and the potential relationship with supplying coronary artery. The dispersion is the most evident in apical segments and increases during the peak stage of DSE. The DSE-induced changes of longitudinal strain, but not strain rate, are opposite in direction in the basal/middle vs. apical part of the LV. Further evaluation is required to determine whether these observations have an impact in the setting of coronary artery disease.
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